Shunmin Li

812 citations
33 papers · 666 indexed · h-index 15
Topics
Mitochondrial Function and Pathology (5 papers)Chronic Kidney Disease and Diabetes (5 papers)Erythropoietin and Anemia Treatment (5 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Shunmin Li

33 papers receiving 661 citations

Peers

Shunmin Li
Comparison fields: 5 of 89
  • Molecular Biology 274
  • Nephrology 122
  • Plant Science 103
  • Epidemiology 101
  • Physiology 99
Replace Dafa Ding with:
Dafa Ding China
Donghai Liu China
Tung‐Wei Hung Taiwan
Lianbo Wei China
Sonia Sifuentes-Franco Mexico
Krit Jaikumkao Thailand
Dileep Kumar India
Mohamed K. El-Kherbetawy Egypt
Qiao-meng Qiu China
Shunmin Li relative to Dafa Ding China Dafa Ding's profile →
Citations per field
00.5×6.9×
Dafa Ding · 1×
Citations per year

Countries citing papers authored by Shunmin Li

Since Specialization
Citations

This map shows the geographic impact of Shunmin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunmin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunmin Li more than expected).

Fields of papers citing papers by Shunmin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunmin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunmin Li. The network helps show where Shunmin Li may publish in the future.

Co-authorship network of co-authors of Shunmin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shunmin Li. A scholar is included among the top collaborators of Shunmin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunmin Li. Shunmin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 14
3 10
4 8
5 5
6 9
7 25
8 3
9 11
10 8
11 8
12 7
13 18
14 23
15 31
16
Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance.
12
17 22
18 14
19 61
20 33

About Shunmin Li

Shunmin Li is a scholar working on Nephrology, Clinical Biochemistry and Geriatrics and Gerontology, having authored 33 papers that have together received 666 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Erythropoietin and Anemia Treatment (5 papers). The work is most often cited by research in Nephrology (122 citations), Geriatrics and Gerontology (40 citations) and Clinical Biochemistry (59 citations). Shunmin Li has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Huili Sun, Xinhui Liu, Kaifang Zeng, Yahan Zhou, Pengxun Han, Shiying Huang, Jiandong Lu, Jianping Chen, Dongtao Wang and Yajun Yang. Their work appears in journals such as PLoS ONE, Journal of Ethnopharmacology and Journal of the Science of Food and Agriculture.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026